Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Globus Medical, Inc. Stockholders
April 24 2015 - 7:11PM
Business Wire
Kirby McInerney LLP is investigating potential claims on behalf
of investors of Globus Medical, Inc. (“Globus” or the “Company”)
(NYSE:GMED) concerning the Company’s and its officers’ possible
violations of federal securities laws. Kirby McInerney LLP is
preparing a class action to recover damages on behalf of injured
Globus shareholders.
On April 22, 2015 the Company announced that its auditors, KPMG
LLP (“KPMG”), had declined to stand for reelection as auditor of
the Company’s financial statements. The Company stated in relevant
part, “[o]n April 16, 2015, KPMG orally notified Globus that upon
the completion of KPMG’s review of the Company’s consolidated
financial statements for the quarterly reporting period ended March
31, 2015 and the filing of the related Quarterly Report on Form
10-Q, KPMG declines to stand for reelection as the independent
registered public accounting firm for the Company. KPMG’s decision
was accepted by the audit committee of the Company’s Board of
Directors.” On this news, shares of Globus fell on April 23, 2015,
as much as $1.33 per share during intraday trading, on unusually
high volume.
If you are a Globus stockholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email
at bwalker@kmllp.com, or telephone at (212) 699-1145, Melissa
Fortunato, Esq. by email at mfortunato@kmllp.com, or telephone at
(212) 699-1141, or toll free at (888) 529-4787, or by filling out
this contact form. There is no cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, whistleblower, antitrust and consumer litigation.
For additional information, please go to www.kmllp.com.
Kirby McInerney LLPJ. Brandon Walker, Esq.,
212-699-1145bwalker@kmllp.com,orMelissa Fortunato, Esq.,
212-699-1141mfortunato@kmllp.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Sep 2023 to Sep 2024